Yahoo Finance's LIVE stock market coverage and analysis.
Yahoo Finance's LIVE stock market coverage and analysis.
Quarterly revenue increased a modest 1.1% year over year to $4.01 billion, translating to a 4.9% decline in adjusted (non-GAAP) net income to $956 million. Thanks to ambitious stock repurchases of $5.89 billion during the fiscal year, however, adjusted net income climbed 4.3% year over year on a per-share basis, to $0.97. By comparison, these results were slightly above the midpoints of Applied Materials' guidance provided in August, which called for revenue of $3.85 billion to $4.15 billion, and earnings per share of $0.92 to $1.00.
Coming into today, shares of the telecommunications company had lost 2.9% in the past month. In that same time, the Computer and Technology sector lost 7.12%, while the S&P 500 lost 6.19%. Meanwhile, our latest consensus estimate is calling for revenue of $48.46 billion, up 16.28% from the prior-year quarter.
8x8 Inc NYSE:EGHT Score: Negative (23) 1 day at current score. Downgraded from Positive on December 10th 2018 View full report here! Summary This company ranked negatively compared to the Technology sector despite 1 positive IHS Markit Category
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed over the past few years. Is Expedia Inc (NASDAQ:EXPE) a bargain?
The market's lack of conviction is perfectly captured by the movements in shares of Apple, CNBC's Jim Cramer says. Conflicting reports on the U.S. economy, U.S.-China trade relations and iPhone sales are testing investors' conviction in the stock and making its trading volatile, the "Mad Money" host says. As investors try to square conflicting reports on the state of the U.S. economy and U.S.-China trade relations, the action in shares of Apple AAPL has become a microcosm of the broader stock market, CNBC's Jim Cramer said Monday.
CBS Television City, the storied TV studio that has hosted such programs as “All in the Family,” “The Ed Sullivan Show” and “$10,000 Pyramid,” has a new owner. CBS Corp. has sold the 25-acre property and sound-stage operation in the Fairfax area of Los Angeles for $750 million to local real estate developer Hackman Capital Partners. Under the deal, Hackman Capital will also have the rights to use the Television City trademark in connection with its operations on the property.
In that same time, the Computer and Technology sector lost 7.12%, while the S&P 500 lost 6.19%. Meanwhile, our latest consensus estimate is calling for revenue of $8.01 billion, up 17.78% from the prior-year quarter. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
London markets were turbulent on Monday, with stocks ending a choppy session in negative territory after U.K. Prime Minister Theresa May delayed indefinitely a parliamentary vote on proposed Brexit plan. In a session that saw the index flip between gains and losses, the U.K.’s FTSE 100 (UK:UKX) ended the day down 0.8% at 6,721.54, after closing down 2.9% at the end of the week on Friday. Financial markets were rattled after Prime Minister Theresa May confirmed that a highly anticipated vote on her Brexit plan, which had been set for Tuesday, had been delayed.
Is the worst over? The requirements for a rally. With Tony Dwyer, Canaccord Genuity, CNBC's Joe Kernen and Bob Pisani, and the Fast Money traders, Tim Seymour, Carter Worth, Steve Grasso and Guy Adami.
Teva Pharmaceutical Industries (NYSE: TEVA), Tivity Health (NASDAQ: TVTY), and Marine Products (NYSE: MPX) were among the worst performers on the day. Teva Pharmaceutical Industries saw its stock close lower by 5% on news that government regulators might take aim at expanding allegations of price fixing among manufacturers of generic drugs. Some investors fear that a probe could now result in greater attention from federal officials, and that could mean more risk for Teva and its peers.
Just days after Aurora Cannabis Inc. announced a supply deal with Mexico’s Farmacias Magistrales SA, the Canadian cannabis company said it has entered a letter of intent to buy all of the company’s outstanding shares in an all-stock deal. Farmacias is Mexico’s first and, for now, only federally licensed importer of raw materials containing THC, the psychoactive ingredient in cannabis, Aurora (ACB)(CA:ACB) said in a statement. The company has the licenses and facilities to store and distribute medical products with more than 1% THC.
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good. However, our research shows this not to be the case. In fact, when it comes to
After slashing his (MU) stock-price target by 40% in October, Susquehanna analyst Mehdi Hosseini has cut his forecast for the chip shares again. In similar fashion, KeyBanc Capital Markets lowered its sales estimates for several chip stocks on Sunday, saying the semiconductor sector is struggling with inventory problems and weaker-than-expected orders. “We are lowering DRAM and NAND bit shipment estimates for 2019 and 2020...we expect lower bit shipments in the February and May quarters due to weaker server and mobile demand,” Hosseini wrote on Monday.
This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on December 6. The rate of decline is significant relative to the trend shown over the past year, and is accelerating.
Short interest is high for VC with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting VC. Over the last month, growth of ETFs holding VC is favorable, with net inflows of $6.69 billion.
BP (BP) closed at $39.37 in the latest trading session, marking a -0.35% move from the prior day. This change lagged the S&P 500's 0.18% gain on the day. At the same time, the Dow added 0.14%, and the tech-heavy Nasdaq gained 0.74%.Coming into today,
Short interest is moderately high for CZR with between 10 and 15% of shares outstanding currently on loan. Over the last month, growth of ETFs holding CZR is favorable, with net inflows of $5.95 billion.
Short interest is extremely low for CYBR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CYBR. ETFs that hold CYBR had net inflows of $472 million over the last one-month.
After an ugly week, Apple (AAPL) shares had a rough start Monday. Qualcomm, (QCOM) Apple’s longtime opponent in court, announced it had won two preliminary injunctions against Apple. Apple was ordered to stop the sale and marketing of seven major iPhone models, from the 6S to iPhone X.
Is International Paper Company (NYSE:IP) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get
CVS Health (CVS) closed the most recent trading day at $73.34, moving -1.01% from the previous trading session. The Retail - Pharmacies and Drug Stores industry currently had an average PEG ratio of 1.13 as of yesterday's close.
This has was narrower than the Medical sector's loss of 3.85% and the S&P 500's loss of 6.19% in that time. Investors will be hoping for strength from ABBV as it approaches its next earnings release, which is expected to be January 25, 2019. On that day, ABBV is projected to report earnings of $1.92 per share, which would represent year-over-year growth of 29.73%.
"October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87. For perspective, there have been only 5 occasions in those 40 years when the S&P 500 declined by greater than 20% from peak to trough.
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. The number of bullish hedge fund positions moved up by 2 lately. NBR was in 39 hedge funds' portfolios at the end of September.